Compare CCSI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCSI | CTKB |
|---|---|---|
| Founded | 2021 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.6M | 541.1M |
| IPO Year | 2022 | 2021 |
| Metric | CCSI | CTKB |
|---|---|---|
| Price | $35.03 | $4.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $37.50 | $5.63 |
| AVG Volume (30 Days) | 144.7K | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $349,696,000.00 | $193,015,000.00 |
| Revenue This Year | $3.33 | $5.42 |
| Revenue Next Year | $2.70 | $7.03 |
| P/E Ratio | $27.08 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $19.42 | $3.09 |
| 52 Week High | $37.30 | $6.18 |
| Indicator | CCSI | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 60.69 | 60.29 |
| Support Level | $25.76 | $4.13 |
| Resistance Level | $36.36 | $4.49 |
| Average True Range (ATR) | 1.62 | 0.23 |
| MACD | -0.18 | 0.05 |
| Stochastic Oscillator | 75.67 | 88.24 |
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.